J.ZarnowskaI.ZarnowskiT.et al
TrustScore This product has not yet been evaluated by our TrustScore system as we have insufficient data
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
So, they dont need to be as efficient
This cutting-edge kit streamlines your workflow with a single wash step, all-liquid reagents, and requires just 5 L of sample
and MIMS-iron, with pro-inflammatory molecular features, including increased expression of MHC class II, ferritin complex, FcY receptor for immunoglobulin, and complement C1 complex (C1QA and C1QB) expressing genes for ribosomal proteins, indicating a role in antigen presentation and perpetuation of inflammation (108)